129 related articles for article (PubMed ID: 15269784)
21. Arsenicals in hematologic cancers.
Novick SC; Warrell RP
Semin Oncol; 2000 Oct; 27(5):495-501. PubMed ID: 11049017
[TBL] [Abstract][Full Text] [Related]
22. Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation.
Grigg A; Kimber R; Szer J
Leukemia; 2003 Sep; 17(9):1916-7; author reply 1918. PubMed ID: 12970801
[No Abstract] [Full Text] [Related]
23. Clinical activity of arsenic trioxide in Burkitt-like lymphoma.
Ravandi F; van Besien K
Leukemia; 2003 Jan; 17(1):271-2. PubMed ID: 12529694
[No Abstract] [Full Text] [Related]
24. Arsenicals and inhibitors of histone deacetylase as anticancer therapy.
Warrell RP
Haematologica; 1999 Jun; 84 Suppl EHA-4():75-7. PubMed ID: 10907475
[No Abstract] [Full Text] [Related]
25. Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience.
Lazo G; Kantarjian H; Estey E; Thomas D; O'Brien S; Cortes J
Cancer; 2003 May; 97(9):2218-24. PubMed ID: 12712474
[TBL] [Abstract][Full Text] [Related]
26. Arsenic trioxide: a new immunomodulatory agent in the management of multiple myeloma.
Hussein MA
Med Oncol; 2001; 18(4):239-42. PubMed ID: 11918450
[TBL] [Abstract][Full Text] [Related]
27. A patient with progressive multiple myeloma treated successfully with arsenic trioxide after allogeneic bone marrow transplantation.
Gesundheit B; Shapira MY; Ackerstein A; Resnik IB; Bitan M; Or R
Acta Haematol; 2007; 117(2):119-21. PubMed ID: 17135719
[TBL] [Abstract][Full Text] [Related]
28. Trials of arsenic trioxide in multiple myeloma.
Hussein MA
Cancer Control; 2003; 10(5):370-4. PubMed ID: 14581891
[TBL] [Abstract][Full Text] [Related]
29. Arsenic trioxide in a hemodialytic patient with acute promyelocytic leukemia.
Yamamoto Y; Sasaki M; Oshimi K; Sugimoto K
Acta Haematol; 2009; 122(1):52-3. PubMed ID: 19816009
[No Abstract] [Full Text] [Related]
30. Multiple myeloma: increasing our treatment options.
Alsina M
Cancer Control; 2003; 10(5):357-8. PubMed ID: 14581889
[No Abstract] [Full Text] [Related]
31. Understanding novel therapeutic agents for multiple myeloma.
Tariman JD
Clin J Oncol Nurs; 2003; 7(5):521-8. PubMed ID: 14603548
[TBL] [Abstract][Full Text] [Related]
32. Novel therapies for multiple myeloma.
Ryoo JJ; Cole CE; Anderson KC
Blood Rev; 2002 Sep; 16(3):167-74. PubMed ID: 12163002
[TBL] [Abstract][Full Text] [Related]
33. Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical results and open questions.
Lengfelder E; Hofmann WK; Nowak D
Expert Rev Anticancer Ther; 2013 Sep; 13(9):1035-43. PubMed ID: 24053202
[TBL] [Abstract][Full Text] [Related]
34. Induction, consolidation, and maintenance therapies with arsenic as a single agent for acute promyelocytic leukaemia in a 11-year follow-up.
Aznab M; Rezaei M
Hematol Oncol; 2017 Mar; 35(1):113-117. PubMed ID: 26310595
[TBL] [Abstract][Full Text] [Related]
35. [Arsenic trioxide as a therapeutic agent in APL].
Emi N
Nihon Rinsho; 2007 Jan; 65 Suppl 1():724-8. PubMed ID: 17474483
[No Abstract] [Full Text] [Related]
36. Arsenic metabolism in multiple myeloma and astrocytoma cells.
Falnoga I; Slejkovec Z; Pucer A; Podgornik H; Tusek-Znidaric M
Biol Trace Elem Res; 2007 Apr; 116(1):5-28. PubMed ID: 17634624
[TBL] [Abstract][Full Text] [Related]
37. Is intravenous arsenic trioxide a useful therapy in myelodysplastic syndromes?
Stone RM
J Clin Oncol; 2006 Jun; 24(16):2414-6. PubMed ID: 16651644
[No Abstract] [Full Text] [Related]
38. [Progress of arsenic trioxide in treating myelodysplastic syndromes].
Xu S; Ma R
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Jan; 29(1):83-4. PubMed ID: 19338160
[No Abstract] [Full Text] [Related]
39. Arsenic trioxide: safety issues and their management.
Au WY; Kwong YL
Acta Pharmacol Sin; 2008 Mar; 29(3):296-304. PubMed ID: 18298894
[TBL] [Abstract][Full Text] [Related]
40. Comparing two arsenic trioxide administration methods in APL therapy.
Zhou J; Meng R; Yang BF
Chin Med J (Engl); 2004 Sep; 117(9):1411-3. PubMed ID: 15377438
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
